[1]
2026. In Silico Insights into the Impact of Deleterious SNPs on the Functioning and Dynamics of TP53 and Its Targeted Therapy by COTI-2 and PRIMA1 in Breast Cancer Patients. UCP Journal of Science & Technology. 3, 2 (Jul. 2026), 31–58. DOI:https://doi.org/10.24312/ucp-jst.03.02.523.